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LABORATORY INVFSTIGATION
Pressure natriuresis and prostaglandin secretion
by perfused rat kidney
GILBERT W. GLEIM, GRACE KA0-Lo, and DAVID L. MAUDE
Department of Physiology, New York Medical College, Valhalla, New York
Pressure natriuresis and prostaglandin secretion by perfused rat kid-
ney. Isolated rat kidneys respond to elevations of perfusion pressure
with an increase in glomerular filtration rate (GFR), filtration fraction
(FF), and sodium excretion (UNaV) and a fall in fractional sodium
reabsorption (FRNa). Significant linear correlations exist between each
of these dependent variables and the renal artery pressure (P). In
control kidneys, pressure natriuresis is seen to result both from an
increase in filtered sodium load and a decrease in FRNa. In kidneys
treated with indomethacin in doses which curtail the release into the
perfusate of prostaglandin E2 (PGE2) and the prostacyclin metabolite,
6-keto-PGF1,, the regression lines relating GFR, FF, and UaV to Pare
shifted to the right. Thus, prostaglandin-inhibited kidneys require
higher pressures than control kidneys to maintain comparable rates of
filtration and sodium excretion. Total renal vascular resistance (RVR) is
also higher in inhibited kidneys. These findings suggest that in the
isolated perfused rat kidney, prostaglandins promote pressure natriure-
sis by maintaining afferent arteriolar dilation. Their inhibition leads to
afferent constriction, which raises RYR, lowers FF and GFR, and
reduces sodium excretion.
Natriurèse d'hyperpression et sécrétion de prostaglandines par le rein
de rat perfuse. Les reins de rat isolés répondent a des élévations de Ia
pression de perfusion par une augmentation de debit de glomdrulaire
filtration (GFR), de La fraction de filtration (FF), et de I'excrétion de
sodium (UNaV) et par une chute de Ia reabsorption fractionnelle de
sodium (FRNa). Des correlations linéaires significatives existent entre
chacune de ces variables dependantes et Ia pression de l'artère rénale
(P). Chez les reins contrOles, Ia natriurése d'hyperpression résulte a Ia
fois d'une augmentation de Ia charge filtrée de sodium et d'une
diminution de FRN. Dans des reins traités par des doses
d'indomethacine supprimant Ic relargage dans le perfusat de
prostaglandine E2 (POE,) et du métabolite de Ia prostacycline, Ia
6-céto-PGE1,,, les droites de regression reliant GFR, FF, et UNV a P
sont décalees vers Ia droite. Ainsj les reins ayant une inhibition des
prostaglandines ont besoin de pressions plus fortes que les reins
contrOles pour maintenir des debits de filtration et d'excrétion sodée
comparables. La résistance vasculaire rénale totale (RVR) est
egalement plus élevée chez les reins inhibés. Ces résultats suggèrent
que dans Ic rein de rat perfuse isolé, les prostaglandines permettent une
natriurése d'hyperpression en maintenant Ia dilatation artériolaire
afférente. Leur inhibition conduit a une constriction afférente, laquelle
augmente RVR, diminue FF et GFR, et réduit l'excrCtion de sodium.
In these experiments we have looked at the effects of
indomethacin and meclofenamate on glomerular filtration rate
(GFR), sodium excretion, vascular resistance, and prostaglan-
din secretion by isolated perfused rat kidney. This work was
prompted by observations suggesting that prostaglandins are
important for the normal excretion of salt, and that distur-
bances in the renal prostaglandin system may play a role in the
genesis of salt-sensitive hypertension in the rat: (1) Rats with
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dietary or drug-induced prostaglandin deficiency have an im-
paired natriuretic response to salt loading [1—5]; (2) rats of
Dahl's salt-sensitive strain, whose kidneys require a higher
perfusion pressure than those of normal animals to maintain salt
excretion [6, 7], have a renal defect in prostaglandin E2 (PGE2)
production 18, 9].
Methods
Sprague-Dawley male rats, weighing 250 to 400 g, were
anesthetized with intraperitoneal sodium pentobarbital and
given 1 ml 10% mannitol intravenously. Their right kidneys
were cannulated following previously described techniques and
then attached to a perfusion apparatus designed to deliver a
recirculated, filtered, and oxygenated perfusion solution to the
kidney at a controlled pressure (6]. In the pressure natriuresis
experiments (seven control and six indomethacin-treated kid-
neys), the renal artery pressure (arterial line pressure corrected
for cannula resistance) was adjusted before each 10-mm clear-
ance period so that a single kidney was perfused at four
different pressures spanning a range from approximately 80 to
150 mm Hg. Considering the 10-to 15-mm initial equilibration
period, the total duration of perfusion averaged 50 to 60 mm.
Because indomethacin-treated kidneys required a higher arte-
rial pressure to initiate urine flow, they were perfused at
somewhat higher pressures than controls. Perfusate flow rates
(F) determined from the time required for a known volume of
perfusate to accumulate in the venous reservoir while its
outflow pump was temporarily turned off, were comparable in
the two groups, for the indomethacin and meclofenamate-
treated kidneys had higher vascular resistances than controls.
Total renal vascular resistance (RVR) was calculated as P/F in
units of mm Hg/ml/minlg. The appearance of POE2 and 6-keto-
PGF1,, in the perfusate was followed in separate experiments
where kidneys were perfused at a fixed pressure of 80 to 100
mm Hg in the control and 120 to 140 mm Hg in prostaglandin-
inhibited kidneys. Perfusate samples were taken for prosta-
glandin assay at the end of the 10-mm equilibration period (P0)
and again 20 (P2) and then 40 mm (P4) later.
Perfusates were bicarbonate-saline solutions containing S
gIlOO g bovine serum albumin, 5.6 m glucose, 10 m lactate,
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and 10 mg/liter inulin. In the prostaglandin inhibition studies
indomethacin (5 or 10 g/ml) or meclofenamate (5 g/ml) was
present in the perfusate from the outset. In these studies the
kidneys were harvested from animals which had received 5
mg/kg of the drug intravenously 30 to 60 mm previously.
Urine specimens and perfusate samples were analyzed for
inulin, sodium, and potassium; clearances were calculated
using conventional methods [61. Where appropriate the renal
functional parameters were normalized to the weight of the
contralateral (unperfused) kidney. Perfusates were analyzed for
PGE2 and 6-keto-PGF10, a stable nonenzymatic hydrolysis
product of prostacyclin [10], as follows: Two-milliliter samples
of perfusate are extracted by acidification to pH 3.0—3.5 with
formic acid in three volumes of ethyl acetate. Organic phase is
pipetted off, dried under nitrogen and resuspended in 0.01 M
phosphate buffer containing 0.1% bovine gamma globulin;
l00-xl aliquots were analyzed for PGE2 and 6-keto-PGF1a using
commercially available RIA kits (Seragen). For the 6-keto-
PGF1a assays, B50/B0 occurred at 124 6 pg/0.l ml, B95/B0 at 8
1; for PGE2 the corresponding values were 225 12 and 21
2 pg/0.l ml.
Using this assay we find a high concentration of PGE2 (983
51 SD, N = 29 pg/ml) in perfusates which have never been in
contact with a kidney (Pblank). This Pblank value is reduced by
about 80% when the extracted samples are treated with sodium
borohydride, which converts PGE2 to the noncrossreacting
prostanoid PGF1. and is indistinguishable from zero in perfus-
ates made up with fatty-acid-free bovine serum albumin. We
assume therefore, that PGE2 is bound to the serum albumin
routinely used in our perfusates. Serum albumin is known to
bind prostaglandins. Although the apparent association con-
stant between PGE2 and bovine serum albumin is low (6 x l0
M 1), the large molar excess of albumin in plasma means that
about 80% of the circulating PGE2 will be protein-bound [11].
Since prostaglandins remain bound to albumin during ethanol
precipitation [12], there is every reason to believe that Cohn's
fraction V will contain PGE2. Protein-bound prostaglandins are
released by acidification [12] and thus would be detected in our
RIA.
In contrast to PGE2, 6-keto-PGF1 was not detected in blank
perfusates. The net rate of prostanoid secretion into the perfus-
ate is calculated as (C/t) x V, where C is the perfusate
concentration change during the time interval t, and V is the
perfusate volume—typically 70 ml.
For statistical analyses of variance and covariance, we fol-
lowed the methods given by Snedecor and Cochran [13—15].
Analysis of variance for repeated measures followed the
method of Winer [16].
Results
Effects of perfusion pressure on function
of the isolated rat kidney
The isolated perfused rat kidney responds to an increase in
perfusion pressure with a rise in GFR, filtration fraction (FF),
and sodium excretion (UNaV), and a fall in fractional sodium
reabsorption (FRNa). There are significant linear correlations
between each of these dependent variables and the renal artery
pressure:
GFR (pl/min/g) = 6.7P (mm Hg) — 140, r = 0.53,
P < 0.01
FF (%) = 0.015P + 0.95, r = 0.42, P < 0.05
UNaV (Eq/min/g) = 0.4lP — 31, r = 0.73, P < 0.01
FRNa (%) = 120 — 0.31P, r = —0.81, P <0.01
The individual data points and the fitted regression lines are
shown in Figure 1.
Effects of indoinethacin on function of the isolated
perfused rat kidney
Kidneys from animals treated with indomethacin and
perfused with solutions containing 10 g/ml also demonstrated
significant increases in GFR, FF, and UNaV with pressure. In





















Fig. 1. Sodium excretion (UNV), GFR,
fractional sodium reabsorption (FRNa), and
filtration fraction (FF) plotted as functions of
renal artery pressure (P) for control pressure
natriuresis experiments. Data comprise 28





Fig. 2. Sodium excretion, GFR, fractional
sodium reabsorption, and filtration fraction
plotted as functions of renal artery pressure
for indomethacin-treated kidneys. The curved
dashed lines are the 95% confidence limits for
the corresponding control regressions (22
clearance periods in six kidneys).
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slope, lay significantly below the corresponding control. The
equations for the indomethacin-treated kidneys, together with F
ratios andP values for their intercepts vis-à-vis the controls [15]
are as follows:
GFR = 8.4P — 670, r = 0.92, P < 0.001 (F = 25.4,
P < 0.01)
FF = 0.03P — 1.8, r = 0.56, P < 0.01 (F = 12.6,
P < 0.01)
UNaV = 0.29P — 25, r = 0.42, P < 0.05 (F = 7.95,
P < 0.01)
The pressure FRNa regression for indomethacin-treated kidneys
is not significant (r =
—0.30), and their adjusted mean [14]
FRNa(84%) does not differ from that of the controls (81%), F =
0.29. These data are shown in Figure 2.
Effects of indomethacin on renal vascular resistance
Unlike the above variables, the total renal vascular resistance
(RYR) was independent of the perfusion pressure both in
control and indomethacin-treated kidneys. Nevertheless, since
perfusion pressures were on the average higher in indomethacin
than in control experiments, we used covariance analysis to
compare the adjusted mean RVRs [14]. The values with in-
domethacin treatment are significantly higher than the controls:
7.03 versus 5.22 mm Hg/ml/min/g (F = 33, P <0.001).
Accumulation of prostaglandins in the perfusate: Effects of
indomethacin and meclofenamate
Perfusate concentrations of PGE2 and 6-keto-PGF1a in the
post-equilibration period sample P0, and in the 20- and 40-mm
specimens are shown in Tables 1 and 2. Since there were no
differences between the effects of 5 g/ml iridomethacin and
meclofenamate on the prostaglandin concentrations, these data
have been combined (IM-5). The data for 10 g/ml indometh-
acm are treated separately (1-10). Two-way analysis of variance
[13] shows PGE2 levels in the 1-10 experiments to be signifi-
cantly less than either control or TM-S (F = 29 and 12,
respectively, P < 0.01), while there is no difference between
control and IM-5 (F = 0.8). In the control, but in neither of the
inhibitor experiments, P0 is significantly higher than the average
1blank (1610 90 vs. 983 95, P < 0.01). In 6-keto-PGF1,, the
concentrations with IM-5 are significantly less than control (F
= 53, P < 0.01), while the values in the TM-b treatment group
are in turn significantly less than IM-5 (F = 21, P < 0.01).
Analysis of variance for repeated measures [161 shows a time-
/7 dependent increase in 6-keto-PGF10, in the control (F = 19, P <0.01) but in neither of the inhibitor experiments.
Discussion
The pressure natriuresis experiments, like other studies on
normal kidneys [17], unclipped kidneys of Goldblatt hyper-
tensive rats [17], and kidneys from salt-sensitive and salt-
resistant Dahl rats [6, 18] show that the isolated rat kidneys
respond to an increase in perfusion pressure with an increase in
sodium excretion. The relationship between these variables is
shown in further detail in the present work which demonstrates
a significant linear correlation between sodium excretion and
renal artery pressure in control kidneys (r = 0.73, P < 0.01)
and, due apparently to the wide scatter in FRNa, a less exact (r
= 0.42), though still significant (P < 0.05) correlation between
these parameters when prostaglandin synthesis is inhibited.
Covariance analysis shows that the UNaV versus P regression of
the inhibited kidneys has a significantly lower intercept than the
controls', indicating that they require higher pressures to main-
tain any given rate of sodium excretion. Because there is a
comparable difference between the indomethacin-treated and
control kidneys in their GFR versus P regression, and because
their adjusted mean fractional sodium reabsorptions are the
same, we conclude that the major influence of prostaglandin
synthesis inhibition on sodium excretion is to lower the filtered
sodium load. The higher vascular resistance and lower filtration
fraction prevailing in the inhibited kidneys suggests further that
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Table 1. Perfusate concentrations of PGE2 (pg/mi) for control kidneys
and for kidneys perfused with 5 g/ml indomethacin or
meclofenamate (IM-5) and for kidneys perfused with
10 g/ml indomethacin (I-10)
Treatment P0 p2 P4
Control (6) l610± 90 1650± 110 1780± 130
TM-S (9)0 1280 170 1630 90 1760 270
Il0(6)c 810 110 900 190 1330 220
Abbreviations: P0, perfusate samples taken for prostaglandin assay at
the end of the 10-mm equilibration period; P2 and P4, 20 and 40 mm
later, respectively.
aData are means SE for the number, in parentheses, of
determinations.
bSignificant differences between P0, P2, and P4 are found only in the
IM-5 experiments (P < 0.01).
cThe values in the 1-10 experiments are significantly less than either
control or IM-5 (P < 0.01).
lower GFR. This inference agrees with several observations
suggesting that prostaglandins affect the afferent renal arteri-
oles: (1) When salt restriction is imposed on indomethacin- or
meclofenamate-treated Munich-Wistar rats, afferent arteriolar
resistance rises and the GFR falls. No similar change occurs
when the prostaglandin system is intact [191. (2) Exogenous
angiotensin II causes a greater afferent arteriolar resistance rise
in prostaglandin-inhibited than in control kidneys [20]. (3)
Indomethacin-treated rats show a rightward displacement of
GFR versus the P regression line when their kidneys are
perfused at pressures below the autoregulatory range [21]. The
coincident rise in vascular resistance and fall in GFR and
filtration fraction in these experiments points to an increase in
afferent arteriolar resistance.
Although hemodynamic factors are largely responsible for
the quantitative differences between intact and prostaglandin-
inhibited kidneys in their responses to perfusion pressure,
changes in tubular function do play a role in pressure natriure-
sis. The importance of tubular factors is shown in the inverse
correlation between fractional sodium reabsorption and perfu-
sion pressure observed in the control kidneys. The effects of
pressure on the tubular handling of sodium have also been
noted in previous studies of isolated perfused rat kidneys [5, 17,
18], as well as in the efficiently autoregulated dog kidney, where
pressure-related changes in sodium excretion can occur in the
absence of measureable alterations in GFR [22, 23]. In the
present experiments the relative importance of tubular and
glomerular factors in pressure natriuresis in control kidneys can
be shown in calculations based on perfusate sodium concentra-
tion and the GFR versus P and FRN0 versus P regression
equations: Sodium excretion rose from 8.2 to 32.1 Eq/m/g as P
went from 100 to 150 mm Hg. If, over the course of this
pressure rise, FRNa had remained at its 100-mm Hg value of
89%, the calculated sodium excretion would have increased
only to 13.3. Thus, the pressure-related fall in FRNa (to 73.5% at
150 mm Hg) makes a major contribution to the increase in
sodium excretion. The FRNa versus P regression which we have
observed points out the need for precise control and documen-
tation of perfusion pressure in studies of tubular sodium trans-
port in isolated rat kidney. Small changes in pressure may
obscure or falsely suggest effects of concurrent experimental
manipulations on sodium reabsorption; furthermore, it will
Table 2. Perfusate concentrations 6-keto-PGF1, (pg/mi) for control
and prostaglandin-inhibited kidneysa
Treatment P0 P2 P4
Control [6] 96 18 112 19 181
IM-5 [12] 66 8 63 14 73 7
1-10 [6] 33 7 43 7 40 6
aThe format is the same as in Figure 1. The values in the IM-5
experiments are significantly less than control (P < 0.001) while 1-10 are
in turn significantly less than IM-5 (P < 0.01). There is a significant rise
in concentration from P0 to P2 to P4 in the control (P < 0.01) but in
neither of the experimental groups.
always be possible to achieve a high percent sodium reabsorp-
tion, suggesting good kidney function, if the perfusion pressure
is kept sufficiently low.
The finding that indomethacin, in doses which curtail
prostaglandin secretion, reduces sodium excretion in the iso-
lated perfused rat kidney agrees with a number of in vivo
studies which suggest that the prostaglandins play a role in the
rat's natriuretic response to salt loading: (1) Rats who become
prostaglandin deficient as a result of a dietary lack of essential
fatty acids maintain a normal GFR, but despite an elevated
arterial blood pressure, have a depressed natriuretic response
to an acutely administered salt load [31. (2) The rise in GFR and
sodium excretion in anesthetized rats following a 1% body
weight saline infusion is prevented by pretreatment with in-
domethacin [21. (3) Conscious rats receiving aspirin have el-
evated blood pressure and expanded extracellular fluid volume.
Their response to acute sodium loading is impaired, though
GFR is no different from the control animals [4]. (4) Acutely
administered indomethacin lowers the sodium excretion by
saline-infused conscious rats without affecting GFR or arterial
blood pressure [11]. (5) Pretreatment with either indomethacin
or meclofenamate lowers sodium excretion by saline-loaded
anesthetized rats. No hemodynamic changes are observed, and
microcatheterization studies suggested that the impaired
natriuresis was due to an increase in sodium reabsorption along
the inner medullary collecting ducts [5].
In all of these studies prostaglandin inhibition was without
effect on GFR, and the blunted natriuresis was in each case
attributable to an increase in tubular sodium reabsorption. In
contrast, the dominant action of prostaglandin synthesis inhibi-
tion on sodium excretion by isolated perfused rat kidney is to
decrease the filtered sodium load. As noted above, this finding
agrees with the considerable body of information suggesting
that the prostaglandins can influence glomerular filtration
[19—211, and the failure of prostaglandin inhibition to influence
glomerular filtration in intact animals given saline loads de-
serves comment. In all of the studies showing an effect of
prostaglandin inhibition on glomerular arterioles the kidneys
had been subjected to some degree of physiological stress, for
example, salt depletion [19], exogenous vasoconstrictors [201,
or low perfusion pressure [21]. In the present experiments the
kidneys, removed as they are from anesthetized laparotomized
rats and subjected to surgical manipulation, are likely to have
suffered mechanical trauma and at least transient episodes of
ischemia. Such insults are the likely cause of the marked
outpouring of PGE2 during the setup and equilibration periods.
Terragno, Terragno, and McGiff [241 have pointed out that the
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prostaglandins, while important for the maintenance of the
renal circulation in acutely stressed animals, may have little
functional significance under more benign conditions. Thus, the
effects of indomethacin and related drugs on GFR, easily
demonstrated in isolated perfused or otherwise stressed kid-
neys producing large amounts of prostaglandins, may be map-
parent in sodium replete intact animals.
The increase in renovascular resistance following indometh-
acm agrees with the work of several investigators [25—27] but
conflicts with the findings of Gerber and Nies [28] that PGE2
lowers renal blood flow and that indomethacin has no effect on
the renal vascular resistance in the rat and of Malik and McGiff
[29], who found PGE2 to potentiate neurally and humorally
mediated vasoconstriction in isolated perfused rat kidney. More
recent studies have, however, suggested that PGE2 is a vaso-
dilator in rat kidney [30].
The prostaglandin assays show that both PGE2 and the
prostacyclin metabolite 6-keto-PGF1 accumulate in the
recirculating perfusate and that their net rate of secretion is
inhibited by indomethacin and meclofenamate. In 6-keto-
PGF, a calculation based on its average concentration change
during the 40-mm interval following the initial equilibration
period (from P0 to P4), the perfusate volume of 70 ml, and an
average kidney weight of 1.5 g indicates that this prostanoid is
added to the perfusate at a net rate of approximately 100
pg/min/g. Okahara, Imanishi, and Yamamoto [31] reported a
6-keto-PGF1 secretory rate in anesthetized dogs of 2.6 ng/min.
On the basis of renal blood flow data they report that this value
translates to 62 pg/min/g, a value similar in magnitude to the
above.
Perfusate concentrations of 6-keto-PGF1 do not increase
with time in the indomethacin or meclofenamate-treated kid-
neys. When present in the perfusate at a concentration of 5
g/ml, these drugs do not lower the P0 concentration, indicating
that 6-keto-PGF1, continues to be released into the perfusate
during the setup period after recirculation of the perfusate has
been established and/or during the equilibration period. In-
domethacin at a concentration of 10 g/ml is, however, associ-
ated with a P0 concentration significantly below control (P <
0.01), but the average value, 33 7 pg/mI is still greater than
zero. Prostacyclin inhibition is then incomplete.
In contrast to 6-keto-PGF1a, whose concentration and secre-
tion rate is roughly the same as in vivo, the behavior of PGE2 in
our system is, we feel, quite extraordinary. In the control
experiments, the average PGE2 concentration in P0, which has
been the recipient of prostaglandins derived from the perfused
kidney during a variable setup and adjustment period and
during the 10-mm equilibration period is 1610 90 pg/ml of
which approximately 1000 pg/ml represents preformed PGE2
bound to the bovine serum albumin. With or without correction
for the exogenous bound prostaglandin, this concentration is far
higher than values typically observed in vivo, 204 pg/ml in dog
renal vein plasma, for example [32]. The PGE2 secretory rate
during the setup and equilibration periods, not niore than a total
of 20 mm, is approximately 1400 pg/min/g, far higher than the 22
to 45 pg/m/g reported for the dog kidney under basal conditions
[32]. PGE2 concentrations do not increase further during the
course of the experiment, indicating that there is a massive
outpouring of PGE2 during the traumatic (for the kidney) setup
period, but little during the actual course of the experiment
when the kidney is left undisturbed. Indomethacin and
meclofenamate apparently prevent the initial release of PGE2,
for the P0 levels both in the IM-5 and 1-10 experiments, 1280
170 and 810 110, do not differ from Pblank. Unexplained is the
small, though statistically significant time-dependent rise in
PGE2 seen in IM-5, but not in control or 1-10 kidneys.
The presence of preformed PGE2 bound to bovine serum
albumin and the subsequent release into the perfusate of large
amounts of endogenous PGE2 may have important effects on
isolated perfused rat kidneys. We ask if these phenomena are
responsible for functional abnormalities of this preparation such
as its reduced sodium reabsorption or low vascular resistance.
The preformed PGE2 seems to be of little significance, for
kidneys perfused with fatty-acid-free albumin, which we have
shown to be substantially free of PGE2, do not show a higher
vascular resistance or improved tubular sodium transport [33].
Endogenous prostaglandins may be largely responsible for the
perfused kidney's vasodilated state, for their inhibition raises
the vascular resistance to levels on the order of 7 mm Hg/ml/m/g
which approximates in vivo values as corrected for the lower
viscosity of cell-free perfusates [6]. There is no evidence for an
effect of endogenous prostaglandins on sodium transport, for
the adjusted mean FRNa is the same in control as in
indomethacin- or meclofenamate-treated kidneys.
In summary, isolated rat kidneys release prostaglandins into
a recirculating perfusate, and the accumulation therein of large
amounts of PGE2 may be in part responsible for the vasodilated
state of this preparation. Indomethacin inhibition of
prostaglandin synthesis increases the vascular resistance and
lowers GFR, filtration fraction, and sodium excretion, suggest-
ing that the renal prostaglandins may promote sodium excretion
by dilating afferent renal arterioles.
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